UnitedHealth Group Incorporated (UNH) Given New $235.00 Price Target at Citigroup Inc.
UnitedHealth Group Incorporated (NYSE:UNH) had its price objective increased by investment analysts at Citigroup Inc. from $213.00 to $235.00 in a research note issued on Wednesday. The firm presently has a “buy” rating on the healthcare conglomerate’s stock. Citigroup Inc.’s target price would indicate a potential upside of 15.26% from the company’s previous close.
Several other equities research analysts have also issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price target on shares of UnitedHealth Group in a report on Friday, July 21st. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a report on Friday, September 1st. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price target (up from $203.00) on shares of UnitedHealth Group in a report on Friday, July 21st. Finally, BidaskClub lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 19th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $211.31.
UnitedHealth Group (NYSE:UNH) opened at 203.89 on Wednesday. The stock’s 50 day moving average is $196.56 and its 200 day moving average is $184.87. The stock has a market capitalization of $197.13 billion, a price-to-earnings ratio of 24.49 and a beta of 0.63. UnitedHealth Group has a one year low of $133.03 and a one year high of $206.62.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same period last year, the company posted $2.17 EPS. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group will post $9.87 EPS for the current year.
In other news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now directly owns 76,058 shares in the company, valued at $14,753,730.84. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $191.71, for a total value of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 76,174 shares of company stock worth $14,981,909. Company insiders own 0.89% of the company’s stock.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Beacon Capital Management bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $0. Proficio Capital Partners bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. Coconut Grove Bank increased its position in shares of UnitedHealth Group by 19.5% during the third quarter. Coconut Grove Bank now owns 736 shares of the healthcare conglomerate’s stock valued at $103,000 after purchasing an additional 120 shares during the period. First Personal Financial Services increased its position in shares of UnitedHealth Group by 36.9% during the third quarter. First Personal Financial Services now owns 742 shares of the healthcare conglomerate’s stock valued at $104,000 after purchasing an additional 200 shares during the period. Finally, Patriot Financial Group Insurance Agency LLC increased its position in shares of UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after purchasing an additional 603 shares during the period. Institutional investors and hedge funds own 86.11% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.